Combined immunodeficiency and Epstein-Barr virus- induced B cell malignancy in humans with inherited CD70 deficiency

Journal of Experimental Medicine

Volumn 214, Issue 1, 2017, Pages 91-106

  Abolhassani, Hassan ^a,b   Edwards, Emily S J ^c,d   Ikinciogullari, Aydan ^e   Jing, Huie ^f   Borte, Stephan ^g   Buggert, Marcus ^a,h   Du, Likun ^a   Matsuda Lennikov, Mami ^f   Romano, Rosa ^a   Caridha, Rozina ^a   Bade, Sangeeta ^f   Zhang, Yu ^f   Frederiksen, Juliet ⁱ   Fang, Mingyan ^a   Bal, Sevgi Kostel ^e   Haskologlu, Sule ^e   Dogu, Figen ^e   Tacyildiz, Nurdan ^e   Matthews, Helen F ^f   McElwee, Joshua J ^j   Gostick, Emma ^k   Price, David A ^f,k   Palendira, Umaimainthan ^l   Aghamohammadi, Asghar ^b,m   Boisson, Bertrand ^n,o,q   Rezaei, Nima ^b,m   Karlsson, Annika C ^a   Lenardo, Michael J ^f   Casanova, Jean Laurent ^n,o,p,q,r   Hammarström, Lennart ^a   Tangye, Stuart G ^c,d   Su, Helen C ^f   Pan Hammarström, Qiang ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ANKARA UNIVERSITY   (Turkey)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g Klinikum St Georg   (Germany)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^j MERCK RESEARCH LABORATORIES   (United States)

^k CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^l UNIVERSITY OF SYDNEY   (Australia)

^m Universal Scientific Education and Research Network   (Iran)

ⁿ ROCKEFELLER UNIVERSITY   (United States)

^o IMAGINE INSTITUTE   (France)

^p HÔPITAL NECKER ENFANTS MALADES   (France)

^q UNIVERSITÉ PARIS DESCARTES   (France)

^r HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CD27 ANTIGEN; CD70 ANTIGEN; IMMUNOGLOBULIN G; NATURAL KILLER CELL RECEPTOR NKG2D; VIRUS CAPSID ANTIGEN; CD70 PROTEIN, HUMAN;

ADULT; ALOPECIA AREATA; ANTIBIOTIC THERAPY; ARTICLE; ASTROCYTOMA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CERVICAL LYMPHADENOPATHY; CHICKENPOX; COMBINED IMMUNODEFICIENCY; CYTOTOXIC T LYMPHOCYTE; DIARRHEA; DIGITAL CLUBBING; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ETHNICITY; FEMALE; FEVER; FOLLOW UP; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN DEFICIENCY; LYMPHADENOPATHY; MALE; MEMORY CELL; MIDDLE AGED; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE CYCLE TREATMENT; OTITIS MEDIA; PEPTIC ULCER; PRIORITY JOURNAL; SPLENOMEGALY; SPONTANEOUS ABORTION; STOMACH BIOPSY; UPPER RESPIRATORY TRACT INFECTION; UTERUS CANCER; VIRUS ENCEPHALITIS; ADOLESCENT; B LYMPHOCYTE; CHILD; COMPLICATION; CYTOTOXICITY; DEFICIENCY; GENETICS; HODGKIN DISEASE; IMMUNE DEFICIENCY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MUTATION; PHYSIOLOGY;

ADOLESCENT; ADULT; ANTIGENS, CD27; ANTIGENS, CD70; B-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOTOXICITY, IMMUNOLOGIC; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOLOGIC MEMORY; MALE; MUTATION;

EID: 85008512074     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20160849     Document Type: Article

References (54)

1. Abolhassani, H., N. Wang, A. Aghamohammadi, N. Rezaei, Y.N. Lee, F. Frugoni, L.D. Notarangelo, Q. Pan-Hammarström, and L. Hammarström. 2014. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J. Allergy Clin. Immunol. 134:1375-1380. http://dx.doi.org/10.1016/j.jaci.2014.04.042
2. Agematsu, K., T. Kobata, F.C. Yang, T. Nakazawa, K. Fukushima, M. Kitahara, T. Mori, K. Sugita, C. Morimoto, and A. Komiyama. 1995. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur. J. Immunol. 25:2825-2829. http://dx.doi.org/10.1002/eji.1830251017
3. Agematsu, K., H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata, C. Morimoto, and A. Komiyama. 1998. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 91:173-180.
4. Agematsu, K., S. Hokibara, H. Nagumo, K. Shinozaki, S. Yamada, and A. Komiyama. 1999. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction. Leuk. Lymphoma. 35:219-225. http://dx.doi.org/10.3109/10428199909145724
5. Aguilar, C., and S. Latour. 2015. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome. J. Clin. Immunol. 35:331-338. http://dx.doi.org/10.1007/s10875-015-0141-9
6. Alkhairy, O.K., R. Perez-Becker, G.J. Driessen, H. Abolhassani, J. van Montfrans, S. Borte, S. Choo, N. Wang, K. Tesselaar, M. Fang, et al. 2015a. Novel mutations in TNF RSF7/CD27: Clinical, immunologic, and genetic characterization of human CD27 deficiency. J. Allergy Clin. Immunol. 136:703-712.e10. http://dx.doi.org/10.1016/j.jaci.2015.02.022
7. Alkhairy, O.K., N. Rezaei, R.R. Graham, H. Abolhassani, S. Borte, K. Hultenby, C. Wu, A. Aghamohammadi, D.A. Williams, T.W. Behrens, et al. 2015b. RAC2 loss-of-function mutation in 2 siblings with characteristics of common variable immunodeficiency. J. Allergy Clin. Immunol. 135:1380-1384.e5. http://dx.doi.org/10.1016/j.jaci.2014.10.039
8. Allam, A., M. Swiecki, W. Vermi, J.D. Ashwell, and M. Colonna. 2014. Dual function of CD70 in viral infection: modulator of early cytokine responses and activator of adaptive responses. J. Immunol. 193:871-878. http://dx.doi.org/10.4049/jimmunol.1302429
9. Borst, J., J. Hendriks, and Y. Xiao. 2005. CD27 and CD70 in T cell and B cell activation. Curr. Opin. Immunol. 17:275-281. http://dx.doi.org/10.1016/j.coi.2005.04.004
10. Bryceson, Y.T., H.G. Ljunggren, and E.O. Long. 2009. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood. 114:2657-2666. http://dx.doi.org/10.1182/blood-2009-01-201632
11. + T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med. 187:1395-1402. http://dx.doi.org/10.1084/jem.187.9.1395
12. Casanova, J.L. 2015a. Human genetic basis of interindividual variability in the course of infection. Proc. Natl. Acad. Sci. USA. 112:E7118-E7127. http://dx.doi.org/10.1073/pnas.1521644112
13. Casanova, J.L. 2015b. Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. USA. 112:E7128-E7137. http://dx.doi.org/10.1073/pnas.1521651112
14. Chaigne-Delalande, B., F.Y. Li, G.M. O'Connor, M.J. Lukacs, P. Jiang, L. Zheng, A. Shatzer, M. Biancalana, S. Pittaluga, H.F. Matthews, et al. 2013. Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 341:186-191. http://dx.doi.org/10.1126/science.1240094
15. Chan, P.K., D.P. Chan, K.F. To, M.Y. Yu, J.L. Cheung, and A.F. Cheng. 2001. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J. Clin. Pathol. 54:401-403. http://dx.doi.org/10.1136/jcp.54.5.401
16. Cinque, P., M. Brytting, L. Vago, A. Castagna, C. Parravicini, N. Zanchetta, A. D'Arminio Monforte, B. Wahren, A. Lazzarin, and A. Linde. 1993. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 342:398-401. http://dx.doi.org/10.1016/0140-6736(93)92814-A
17. Cohen, J.I. 2015. Primary immunodeficiencies associated with EBV disease. Curr. Top. Microbiol. Immunol. 390:241-265.
18. De Colvenaer, V., S. Taveirne, M. Delforche, M. De Smedt, B. Vandekerckhove, T. Taghon, L. Boon, J. Plum, and G. Leclercq. 2011. CD27-deficient mice show normal NK-cell differentiation but impaired function upon stimulation. Immunol. Cell Biol. 89:803-811. http://dx.doi.org/10.1038/icb.2010.171
19. de Miranda, N.F., K. Georgiou, L. Chen, C. Wu, Z. Gao, A. Zaravinos, S. Lisboa, G. Enblad, M.R. Teixeira, Y. Zeng, et al. 2014. Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood. 124:2544-2553. http://dx.doi.org/10.1182/blood-2013-12-546309
20. Faitelson, Y., and E. Grunebaum. 2014. Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin. Immunol. 155:118-125. http://dx.doi.org/10.1016/j.clim.2014.09.008
21. Goodwin, R.G., M.R. Alderson, C.A. Smith, R.J. Armitage, T. VandenBos, R. Jerzy, T.W. Tough, M.A. Schoenborn, T. Davis-Smith, K. Hennen, et al. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73:447-456. http://dx.doi.org/10.1016/0092-8674(93)90133-B
22. Han, B.K., N.J. Olsen, and A. Bottaro. 2016. The CD27-CD70 pathway and pathogenesis of autoimmune disease. Semin. Arthritis Rheum. 45:496-501. http://dx.doi.org/10.1016/j.semarthrit.2015.08.001
23. Hendriks, J., L.A. Gravestein, K. Tesselaar, R.A. van Lier, T.N. Schumacher, and J. Borst. 2000. CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol. 1:433-440. http://dx.doi.org/10.1038/80877
24. Hendriks, J., Y. Xiao, and J. Borst. 2003. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198:1369-1380. http://dx.doi.org/10.1084/jem.20030916
25. Hintzen, R.Q., S.M. Lens, K. Lammers, H. Kuiper, M.P. Beckmann, and R.A. van Lier. 1995. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154:2612-2623.
26. + T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195:893-905. http://dx.doi.org/10.1084/jem.20011692
27. + T-cell function in X-linked lymphoproliferative disease is restricted to SLAM familypositive B-cell targets. Blood. 116:3249-3257. http://dx.doi.org/10.1182/blood-2009-09-238832
28. Itan, Y., L. Shang, B. Boisson, E. Patin, A. Bolze, M. Moncada-Vélez, E. Scott, M.J. Ciancanelli, F.G. Lafaille, J.G. Markle, et al. 2015. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. USA. 112:13615-13620. http://dx.doi.org/10.1073/pnas.1518646112
29. Itan, Y., L. Shang, B. Boisson, M.J. Ciancanelli, J.G. Markle, R. Martinez-Barricarte, E. Scott, I. Shah, P.D. Stenson, J. Gleeson, et al. 2016. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods. 13:109-110. http://dx.doi.org/10.1038/nmeth.3739
30. Jacobs, J., V. Deschoolmeester, K. Zwaenepoel, C. Rolfo, K. Silence, S. Rottey, F. Lardon, E. Smits, and P. Pauwels. 2015. CD70: An emerging target in cancer immunotherapy. Pharmacol. Ther. 155:1-10. http://dx.doi.org/10.1016/j.pharmthera.2015.07.007
31. Jacquot, S., T. Kobata, S. Iwata, C. Morimoto, and S.F. Schlossman. 1997. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J. Immunol. 159:2652-2657.
32. Jung, J., J. Choe, L. Li, and Y.S. Choi. 2000. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur. J. Immunol. 30:2437-2443. http://dx.doi.org/10.1002/1521-4141(2000)30:8<2437::AID-IMMU2437>3.0.CO;2-M
33. Kircher, M., D.M. Witten, P. Jain, B.J. O'Roak, G.M. Cooper, and J. Shendure. 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46:310-315. http://dx.doi.org/10.1038/ng.2892
34. Kwon, H.J., G.E. Choi, S. Ryu, S.J. Kwon, S.C. Kim, C. Booth, K.E. Nichols, and H.S. Kim. 2016. Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition. Nat. Commun. 7:11686. http://dx.doi.org/10.1038/ncomms11686
35. Lens, S.M., R. de Jong, B. Hooibrink, G. Koopman, S.T. Pals, M.H. van Oers, and R.A. van Lier. 1996. Phenotype and function of human B cells expressing CD70 (CD27 ligand). Eur. J. Immunol. 26:2964-2971. http://dx.doi.org/10.1002/eji.1830261223
36. Munitic, I., M. Kuka, A. Allam, J.P. Scoville, and J.D. Ashwell. 2013. CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. J. Immunol. 190:1169-1179. http://dx.doi.org/10.4049/jimmunol.1202353
37. Nolte, M.A., R.W. van Olffen, K.P. van Gisbergen, and R.A. van Lier. 2009. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol. Rev. 229:216-231. http://dx.doi.org/10.1111/j.1600-065X.2009.00774.x
38. Palendira, U., and A.B. Rickinson. 2015. Primary immunodeficiencies and the control of Epstein-Barr virus infection. Ann. N. Y. Acad. Sci. 1356:22-44. http://dx.doi.org/10.1111/nyas.12937
39. Palendira, U., C. Low, A. Chan, A.D. Hislop, E. Ho, T.G. Phan, E. Deenick, M.C. Cook, D.S. Riminton, S. Choo, et al. 2011. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP. PLoS Biol. 9:e1001187. http://dx.doi.org/10.1371/journal.pbio.1001187
40. Picard, C., W. Al-Herz, A. Bousfiha, J.L. Casanova, T. Chatila, M.E. Conley, C. Cunningham-Rundles, A. Etzioni, S.M. Holland, C. Klein, et al. 2015. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J. Clin. Immunol. 35:696-726. http://dx.doi.org/10.1007/s10875-015-0201-1
41. + T cell populations specific for persistent DNA viruses. J. Exp. Med. 202:1349-1361. http://dx.doi.org/10.1084/jem.20051357
42. Roederer, M., J.L. Nozzi, and M.C. Nason. 2011. SPI CE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 79A:167-174. http://dx.doi.org/10.1002/cyto.a.21015
43. Salzer, E., S. Daschkey, S. Choo, M. Gombert, E. Santos-Valente, S. Ginzel, M. Schwendinger, O.A. Haas, G. Fritsch, W.F. Pickl, et al. 2013. Combined immunodeficiency with life-threatening EBV-associated lymphoproliferative disorder in patients lacking functional CD27. Haematologica. 98:473-478. http://dx.doi.org/10.3324/haematol.2012.068791
44. Scholtysik, R., I. Nagel, M. Kreuz, I. Vater, M. Giefing, C. Schwaenen, S. Wessendorf, L. Trümper, M. Loeffler, R. Siebert, and R. Küppers. 2012. Recurrent deletions of the TNF SF7 and TNF SF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas. Int. J. Cancer. 131:E830-E835. http://dx.doi.org/10.1002/ijc.27416
45. Scott, E.M., A. Halees, Y. Itan, E.G. Spencer, Y. He, M.A. Azab, S.B. Gabriel, A. Belkadi, B. Boisson, L. Abel, et al. Greater Middle East Variome Consortium. 2016. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat. Genet. 48:1071-1076. http://dx.doi.org/10.1038/ng.3592
46. Silva, A., D.M. Andrews, A.G. Brooks, M.J. Smyth, and Y. Hayakawa. 2008. Application of CD27 as a marker for distinguishing human NK cell subsets. Int. Immunol. 20:625-630. http://dx.doi.org/10.1093/intimm/dxn022
47. Tangye, S.G. 2014. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP. J. Clin. Immunol. 34:772-779. http://dx.doi.org/10.1007/s10875-014-0083-7
48. Tangye, S.G., Y.J. Liu, G. Aversa, J.H. Phillips, and J.E. de Vries. 1998. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188:1691-1703. http://dx.doi.org/10.1084/jem.188.9.1691
49. Taylor, G.S., H.M. Long, J.M. Brooks, A.B. Rickinson, and A.D. Hislop. 2015. The immunology of Epstein-Barr virus-induced disease. Annu. Rev. Immunol. 33:787-821. http://dx.doi.org/10.1146/annurev-immunol-032414-112326
50. Tesselaar, K., L.A. Gravestein, G.M. van Schijndel, J. Borst, and R.A. van Lier. 1997. Characterization of murine CD70, the ligand of the TNF receptor family member CD27. J. Immunol. 159:4959-4965.
51. Tesselaar, K., Y. Xiao, R. Arens, G.M. van Schijndel, D.H. Schuurhuis, R.E. Mebius, J. Borst, and R.A. van Lier. 2003. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170:33-40. http://dx.doi.org/10.4049/jimmunol.170.1.33
52. van Montfrans, J.M., A.I. Hoepelman, S. Otto, M. van Gijn, L. van de Corput, R.A. de Weger, L. Monaco-Shawver, P.P. Banerjee, E.A. Sanders, C.M. Jol-van der Zijde, et al. 2012. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J. Allergy Clin. Immunol. 129:787-793.e6. http://dx.doi.org/10.1016/j.jaci.2011.11.013
53. Vossen, M.T., M. Matmati, K.M. Hertoghs, P.A. Baars, M.R. Gent, G. Leclercq, J. Hamann, T.W. Kuijpers, and R.A. van Lier. 2008. CD27 defines phenotypically and functionally different human NK cell subsets. J. Immunol. 180:3739-3745. http://dx.doi.org/10.4049/jimmunol.180.6.3739
54. Waggoner, S.N., and V. Kumar. 2012. Evolving role of 2B4/CD244 in T and NK cell responses during virus infection. Front. Immunol. 3:377. http://dx.doi.org/10.3389/fimmu.2012.00377